60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 4.48. At the close of trading, the stock’s price was $0.83, to imply an increase of 0.32% or $0.0 in intraday trading. The SXTP share’s 52-week high remains $11.88, putting it -1331.33% down since that peak but still an impressive 15.66% since price per share fell to its 52-week low of $0.70. The company has a valuation of $1.91M, with an average of 1.64 million shares in intraday trading volume over the past 10 days and average of 574.52K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for 60 Degrees Pharmaceuticals Inc (SXTP), translating to a mean rating of 2.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give SXTP a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
After registering a 0.32% upside in the last session, 60 Degrees Pharmaceuticals Inc (SXTP) has traded red over the past five days. The 5-day price performance for the stock is -21.14%, and -45.17% over 30 days. With these gigs, the year-to-date price performance is -35.81%. Short interest in 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) saw shorts transact 37296.0 shares and set a 0.34 days time to cover.
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
Looking at statistics comparing 60 Degrees Pharmaceuticals Inc share performance against respective industry, we note that the company has outperformed competitors. 60 Degrees Pharmaceuticals Inc (SXTP) shares are -71.95% down over the last 6 months, with its year-to-date growth rate higher than industry average at 79.42% against 16.60%.
SXTP Dividends
60 Degrees Pharmaceuticals Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
60 Degrees Pharmaceuticals Inc insiders hold 10.58% of total outstanding shares, with institutional holders owning 1.25% of the shares at 1.40% float percentage. In total, 1.25% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund as the top two Mutual Funds with the largest holdings of the 60 Degrees Pharmaceuticals Inc (SXTP) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 3.88 shares. This is just over 0.17% of the total shares, with a market valuation of $3208.0. Data from the same date shows that the other fund manager holds a little less at 2.14, or 0.09% of the shares, all valued at about 1769.0.
